Pelage Pharmaceuticals, Inc. — Form D
Pelage Pharmaceuticals, Inc. of LOS ANGELES, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-11-24. The offering totals $120.0M, of which $120.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2025-11-24
- Form: D
- Accession: 0001982875-25-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $120.0M
- Amount sold: $120.0M
- Investors: 5
- Date of first sale: 2025-09-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-564886
Issuer
- Name: Pelage Pharmaceuticals, Inc.
- CIK: 0001982875
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 907 WESTWOOD BLVD #384, LOS ANGELES, CA, 90024
- Phone: 949-244-9904
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Cathy Edward Friedman | Director | Los Angeles, CA |
| Daniel Gil | Director | Los Angeles, CA |
| Richard Edward Heyman | Director | Los Angeles, CA |
| William Edward Lowry | Director | Los Angeles, CA |
| Daniel Gil | Executive Officer | Los Angeles, CA |
| William Edward Lowry | Executive Officer | Los Angeles, CA |
| Christina Edward Weng | Executive Officer | Los Angeles, CA |
| Nathan Edward Wheeler | Executive Officer | Los Angeles, CA |
| Heather Edward Christofk | Executive Officer | Los Angeles, CA |
Other filings by this issuer (2)
More